Comparisons of microRNA Patterns in Plasma before and after Tumor Removal Reveal New Biomarkers of Lung Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Aushev, Vasily N ^a,b   Zborovskaya, Irina B ^b   Laktionov, Konstantin K ^b   Girard, Nicolas ^c   Cros, Marie Pierre ^a   Herceg, Zdenko ^a   Krutovskikh, Vladimir ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 19A; MICRORNA 19B; MICRORNA 205; MICRORNA 20A; MICRORNA 30B; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER CELL; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; HUMAN CELL; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MALE; MICRORNA BLOOD LEVEL; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; RNA ANALYSIS; RNA SYNTHESIS;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84885161300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078649     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. doi:10.3322/canjclin.55.2.74. PubMed: 15761078.
2. Krutovskikh VA, Herceg Z, (2010) Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 32: 894-904. doi:10.1002/bies.201000040. PubMed: 21105295.
3. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M, (2012) microRNAs in cancer management. Lancet Oncol 13: e249-e258. doi:10.1016/S1470-2045(12)70073-6. PubMed: 22652233.
4. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269. doi:10.1038/nrc1840. PubMed: 16557279.
5. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLOS ONE 3: e3694. doi:10.1371/journal.pone.0003694. PubMed: 19002258.
6. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006. doi:10.1038/cr.2008.282. PubMed: 18766170.
7. Mraz M, Malinova K, Mayer J, Pospisilova S, (2009) MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun 390: 1-4. doi:10.1016/j.bbrc.2009.09.061. PubMed: 19769940.
8. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH, (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46. doi:10.3816/CLC.2009.n.006. PubMed: 19289371.
9. Weiland M, Gao XH, Zhou L, Mi QS, (2012) Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 9: 850-859. doi:10.4161/rna.20378. PubMed: 22699556.
10. Kelly BD, Miller N, Healy NA, Walsh K, Kerin MJ, (2013) A review of expression profiling of circulating microRNAs in men with prostate cancer. BJU Int 111: 17-21. doi:10.1111/bju.12137. PubMed: 22612403.
11. Ma R, Jiang T, Kang X, (2012) Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 31: 38. doi:10.1186/1756-9966-31-38. PubMed: 22546315.
12. Cortez MA, Welsh JW, Calin GA, (2012) Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res 195: 151-161. doi:10.1007/978-3-642-28160-0_13. PubMed: 22527502.
13. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, et al. (2009) MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69: 5776-5783. doi:10.1158/0008-5472.CAN-09-0587. PubMed: 19584273.
14. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, et al. (2012) Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130: 1378-1386. doi:10.1002/ijc.26153. PubMed: 21544802.
15. Boeri M, Verri C, Conte D, Roz L, Modena P, et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108: 3713-3718. doi:10.1073/pnas.1100048108. PubMed: 21300873.
16. Yang Y, Li X, Yang Q, Wang X, Zhou Y, et al. (2010) The role of microRNA in human lung squamous cell carcinoma. Cancer Genet Cytogenet 200: 127-133. doi:10.1016/j.cancergencyto.2010.03.014. PubMed: 20620595.
17. Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, et al. (2011) Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol 4: 575-586. PubMed: 21904633.
18. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91: 579-587. doi:10.1038/labinvest.2010.194. PubMed: 21116241.
19. Davidson MR, Larsen JE, Yang IA, Hayward NK, Clarke BE, et al. (2010) MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLOS ONE 5: e12560. doi:10.1371/journal.pone.0012560. PubMed: 20838434.
20. Chen X, Hu Z, Wang W, Ba Y, Ma L, et al. (2012) Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 130: 1620-1628. doi:10.1002/ijc.26177. PubMed: 21557218.
21. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, et al. (2011) A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 3: 495-503.
22. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726. doi:10.1200/JCO.2009.24.9342. PubMed: 20194856.
23. Fairbanks VF, Ziesmer SC, O'Brien PC, (1992) Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem 38: 132-140. PubMed: 1733585.
24. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, et al. (2010) Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLOS ONE 5: e13247. doi:10.1371/journal.pone.0013247. PubMed: 20949044.
25. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, et al. (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLOS ONE 6: e24145. doi:10.1371/journal.pone.0024145. PubMed: 21909417.
26. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497. doi:10.1158/1940-6207.CAPR-11-0370.
27. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518. doi:10.1073/pnas.0804549105. PubMed: 18663219.
28. Wright GW, Simon RM, (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448-2455. doi:10.1093/bioinformatics/btg345. PubMed: 14668230.
29. Le HB, Zhu WY, Chen DD, He JY, Huang YY, et al. (2012) Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med Oncol 29: 3190-3197. doi:10.1007/s12032-012-0303-z. PubMed: 22782668.
30. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008. doi:10.1073/pnas.1019055108. PubMed: 21383194.
31. Winter J, Diederichs S, (2011) Argonaute proteins regulate microRNA stability: Increased microRNA abundance by Argonaute proteins is due to microRNA stabilization. RNA Biol 8: 1149-1157. doi:10.4161/rna.8.6.17665. PubMed: 21941127.
32. Yao B, La LB, Chen YC, Chang LJ, Chan EK, (2012) Defining a new role of GW182 in maintaining miRNA stability. EMBO Rep 13: 1102-1108. doi:10.1038/embor.2012.160. PubMed: 23090477.
33. Boon RA, Vickers KC, (2013) Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 33: 186-192. doi:10.1161/ATVBAHA.112.300139. PubMed: 23325475.
34. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126. doi:10.1002/ijc.25007. PubMed: 19876917.
35. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505. doi:10.1097/SLA.0b013e3181cc939f. PubMed: 20134314.
36. Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, et al. (2010) Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 16: 360-364. doi:10.1111/j.1601-0825.2009.01646.x. PubMed: 20233326.
37. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592. doi:10.1158/1078-0432.CCR-07-0666. PubMed: 18451220.
38. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-1179. doi:10.1038/sj.bjc.6605608. PubMed: 20234369.
39. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, et al. (2010) Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 16: 610-619. doi:10.1158/1078-0432.CCR-09-2638. PubMed: 20068099.
40. Lu Y, Govindan R, Wang L, Liu PY, Goodgame B, et al. (2012) MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 33: 1046-1054. doi:10.1093/carcin/bgs100. PubMed: 22331473.
41. Jiang M, Zhang P, Hu G, Xiao Z, Xu F, et al. (2013) Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients. Mol Cell Biochem. PubMed: 23881177.
42. Hamamoto J, Soejima K, Yoda S, Naoki K, Nakayama S, et al. (2013) Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep 8: 456-462. PubMed: 23759980.
43. Qin AY, Zhang XW, Liu L, Yu JP, Li H, et al. (2013) MiR-205 in cancer: an angel or a devil? Eur J Cell Biol 92: 54-60. doi:10.1016/j.ejcb.2012.11.002. PubMed: 23279926.
44. Li C, Finkelstein D, Sherr CJ, (2013) Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells. Proc Natl Acad Sci U S A 110: E1112-E1121. doi:10.1073/pnas.1302184110. PubMed: 23487795.
45. Lin Q, Chen T, Lin Q, Lin G, Lin J, et al. (2013) Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer. J Surg Oncol 107: 767-771. doi:10.1002/jso.23312. PubMed: 23609137.
46. Shao C, Yu Y, Yu L, Pei Y, Feng Q, et al. (2012) Amplification and up-regulation of microRNA-30b in oral squamous cell cancers. Arch Oral Biol 57: 1012-1017. doi:10.1016/j.archoralbio.2012.04.002. PubMed: 22542163.
47. Yabushita S, Fukamachi K, Tanaka H, Sumida K, Deguchi Y, et al. (2012) Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Pancreas 41: 1013-1018. doi:10.1097/MPA.0b013e31824ac3a5. PubMed: 22513294.
48. Palma J, Yaddanapudi SC, Pigati L, Havens MA, Jeong S, et al. (2012) MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res 40: 9125-9138. doi:10.1093/nar/gks656. PubMed: 22772984.
49. Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, et al. (2010) Selective release of microRNA species from normal and malignant mammary epithelial cells. PLOS ONE 5: e13515. doi:10.1371/journal.pone.0013515. PubMed: 20976003.